When considering the limitations of using CRP as a biomarker for inflammation in patients with atherosclerosis and diabetes, several important factors must be taken into account: CRP is a non-specific marker of inflammation, while it can arise from various conditions, including infections, autoimmune diseases or other inflammatory disorders. Here, CRP is linked to infection.